Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia.
Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia.
复制标题
DOI:
10.1084/jem.20130295
复制
发表时间:
2014-01-13
期刊:
影响因子:
--
通讯作者:
Graham CH
中科院分区:
文献类型:
--
作者:
Cotechini T;Komisarenko M;Sperou A;Macdonald-Goodfellow S;Adams MA;Graham CH
Abnormal maternal inflammation leads to TNF-mediated fetal growth restriction and some features of preeclampsia that can be ameliorated with the nitric oxide mimetic nitroglycerin. Fetal growth restriction (FGR) and preeclampsia (PE) are often associated with abnormal maternal inflammation, deficient spiral artery (SA) remodeling, and altered uteroplacental perfusion. Here, we provide evidence of a novel mechanistic link between abnormal maternal inflammation and the development of FGR with features of PE. Using a model in which pregnant rats are administered low-dose lipopolysaccharide (LPS) on gestational days 13.5–16.5, we show that abnormal inflammation resulted in FGR mediated by tumor necrosis factor-α (TNF). Inflammation was also associated with deficient trophoblast invasion and SA remodeling, as well as with altered uteroplacental hemodynamics and placental nitrosative stress. Moreover, inflammation increased maternal mean arterial pressure (MAP) and was associated with renal structural alterations and proteinuria characteristic of PE. Finally, transdermal administration of the nitric oxide (NO) mimetic glyceryl trinitrate prevented altered uteroplacental perfusion, LPS-induced inflammation, placental nitrosative stress, renal structural and functional alterations, increase in MAP, and FGR. These findings demonstrate that maternal inflammation can lead to severe pregnancy complications via a mechanism that involves increased maternal levels of TNF. Our study provides a rationale for the use of antiinflammatory agents or NO-mimetics in the treatment and/or prevention of inflammation-associated pregnancy complications.
登录
查看更多内容
影响因子:
7.1
作者:
Acharya, G;Wilsgaard, T;Kiserud, T
通讯作者:
Kiserud, T
影响因子:
1.5
作者:
BRIDGMAN, J
通讯作者:
BRIDGMAN, J
影响因子:
168.9
作者:
GARDOSI, J;CHANG, A;SYMONDS, EM
通讯作者:
SYMONDS, EM
影响因子:
6.7
作者:
Falcon, Bani J.;Cotechini, Tiziana;Graham, Charles H.
通讯作者:
Graham, Charles H.
影响因子:
3.8
作者:
Burton, G. J.;Woods, A. W.;Jauniaux, E.;Kingdom, J. C. P.
通讯作者:
Kingdom, J. C. P.